Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2.
Cunningham-Rundles
C
C
Department of Medicine, Mount Sinai Medical Center, New York, NY 10029.
Kazbay
K
K
Hassett
J
J
Zhou
Z
Z
Mayer
L
L
D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D017074:Common Variable Immunodeficiency / Q000276:immunology* / Q000628:therapy*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D007376:Interleukin-2 / Q000096:biosynthesis / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors
D007136:Immunoglobulins; D007376:Interleukin-2; D015850:Interleukin-6; D011994:Recombinant Proteins